BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34085796)

  • 1. Sentinel lymph Node mapping versus systematic pelvic lymphadenectomy on the prognosis for patients with intermediate-high-risk Endometrial Cancer confined to the uterus before surgery: trial protocol for a non-inferiority randomized controlled trial (SNEC trial).
    Guan J; Xue Y; Zang RY; Liu JH; Zhu JQ; Zheng Y; Wang B; Wang HY; Chen XJ
    J Gynecol Oncol; 2021 Jul; 32(4):e60. PubMed ID: 34085796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter noninferior randomized controlled study of sentinel lymph node biopsy alone versus sentinel lymph node biopsy plus lymphadenectomy for patients with stage I endometrial cancer, INSEC trial concept.
    Guo Y; Sun L; Chen X; Wen Q; Shao Z; Tang X; Shi X; Wang J; Zhang Y; Zhu T
    BMC Cancer; 2023 Dec; 23(1):1184. PubMed ID: 38041023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison between sentinel lymph node mapping using indocyanine green plus a fluorescent camera versus lymph node dissection in clinical stage I-II endometrial cancer: a Korean Gynecologic Oncology Group trial (KGOG2029/SELYE).
    Park JY; Kim JH; Baek MH; Park E; Kim SW
    J Gynecol Oncol; 2022 Nov; 33(6):e73. PubMed ID: 36047376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
    Rossi EC; Kowalski LD; Scalici J; Cantrell L; Schuler K; Hanna RK; Method M; Ade M; Ivanova A; Boggess JF
    Lancet Oncol; 2017 Mar; 18(3):384-392. PubMed ID: 28159465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node mapping versus sentinel lymph node mapping with systematic lymphadenectomy in endometrial cancer: an open-label, non-inferiority, randomized trial (ALICE trial).
    Baiocchi G; Andrade CEMC; Ribeiro R; Moretti-Marques R; Tsunoda AT; Alvarenga-Bezerra V; Lopes A; Costa RLR; Kumagai LY; Badiglian-Filho L; Faloppa CC; Mantoan H; De Brot L; Dos Reis R; Goncalves BT
    Int J Gynecol Cancer; 2022 May; 32(5):676-679. PubMed ID: 35236752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value and best way for detection of Sentinel lymph node in early stage endometrial cancer: Selective lymphadenectomy algorithm.
    El-Agwany AS; Meleis MH
    Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():35-39. PubMed ID: 29660577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel node mapping vs. sentinel node mapping plus back-up lymphadenectomy in high-risk endometrial cancer patients: Results from a multi-institutional study.
    Bogani G; Papadia A; Buda A; Casarin J; Di Donato V; Gasparri ML; Plotti F; Pinelli C; Paderno MC; Lopez S; Perrone AM; Barra F; Guerrisi R; Brusadelli C; Cromi A; Ferrari D; Chiapp V; Signorelli M; Leone Roberti Maggiore U; Ditto A; Palaia I; Ferrero S; De Iaco P; Angioli R; Panici PB; Ghezzi F; Landoni F; Mueller MD; Raspagliesi F
    Gynecol Oncol; 2021 Apr; 161(1):122-129. PubMed ID: 33485641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis.
    Kennard JA; Stephens AJ; Ahmad S; Zhu X; Singh C; McKenzie ND; Kendrick JE; Holloway RW
    Gynecol Oncol; 2019 Jul; 154(1):53-59. PubMed ID: 31027899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficiency of a combined injection technique for sentinel lymph node mapping in intermediate-high-risk endometrial cancer.
    Wang Q; Wang B; Wang L; Xue Y; Shan W; Luo X; Wang C; Chen X
    J Surg Oncol; 2021 Dec; 124(8):1551-1560. PubMed ID: 34496048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
    Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
    Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel Lymph Node Mapping in Endometrial Cancer: An Update.
    Khoury-Collado F; St Clair C; Abu-Rustum NR
    Oncologist; 2016 Apr; 21(4):461-6. PubMed ID: 26961924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of sentinel lymph node mapping on survival in patients with high-risk endometrial cancer in the early stage: A matched cohort study.
    Jaafar E; Gaultier V; Wohrer H; Estevez JP; Gonthier C; Koskas M
    Int J Gynaecol Obstet; 2024 May; 165(2):677-684. PubMed ID: 38226675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of sentinel lymph node mapping and uterine frozen section examination to reduce side-specific lymphadenectomy rate in endometrial cancer: a Turkish Gynecologic Oncology Group study (TRSGO-SLN-002).
    Altin D; Taşkın S; Kahramanoglu I; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Naki MM; Güngör M; Köse MF; Ortac F; Arvas M; Ayhan A; Taskiran C
    Int J Gynecol Cancer; 2020 Jul; 30(7):1005-1011. PubMed ID: 32474451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node biopsy in early stage endometrial cancer: a Turkish gynecologic oncology group study (TRSGO-SLN-001).
    Taşkın S; Altin D; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Kahramanoglu I; Naki MM; Güngör M; Köse F; Ortac F; Arvas M; Ayhan A; Taskiran C
    Int J Gynecol Cancer; 2020 Mar; 30(3):299-304. PubMed ID: 31857440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes for patients with high-risk endometrial cancer undergoing sentinel lymph node assessment versus full lymphadenectomy.
    Holtzman S; Stoffels G; Flint M; Carr C; Prasad-Hayes M; Zeligs K; Blank SV
    Gynecol Oncol; 2023 Jul; 174():273-277. PubMed ID: 37270906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel node navigation surgery in cervical and endometrial cancer: a review.
    Niikura H; Tsuji K; Tokunaga H; Shimada M; Ishikawa M; Yaegashi N
    Jpn J Clin Oncol; 2019 Jun; 49(6):495-500. PubMed ID: 31070770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004).
    Altin D; Taskin S; Tokgozoglu N; Vatansever D; Guler AH; Gungor M; Tasci T; Turan H; Kahramanoglu I; Yalcin I; Celik C; Kose F; Ortac F; Arvas M; Ayhan A; Taskiran C
    J Surg Oncol; 2021 Feb; 123(2):638-645. PubMed ID: 33259650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node biopsy for robotic-assisted endometrial cancer staging: further improvement of perioperative outcomes.
    Casarin J; Multinu F; Tortorella L; Cappuccio S; Weaver AL; Ghezzi F; Cilby W; Kumar A; Langstraat C; Glaser G; Mariani A
    Int J Gynecol Cancer; 2020 Jan; 30(1):41-47. PubMed ID: 31780567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact on survival of two different staging strategies in apparent early stage endometrial cancer comparing sentinel lymph nodes mapping algorithm and selective lymphadenectomy: An Italian retrospective analysis of two reference centers.
    Buda A; Di Martino G; Restaino S; De Ponti E; Monterossi G; Giuliani D; Ercoli A; Dell'Orto F; Dinoi G; Grassi T; Scambia G; Fanfani F
    Gynecol Oncol; 2017 Dec; 147(3):528-534. PubMed ID: 29032824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of progression-free survival outcome of sentinel node biopsy without ultrastaging versus lymphadenectomy in endometrial cancer: a propensity-matched analysis.
    Lee D; Kim YN; Cho SH; Yoon HS; Kim YT; Kim S; Kim SW
    J Gynecol Oncol; 2023 Nov; 34(6):e79. PubMed ID: 37477102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.